Revium Rx. Stock

Stocks

Delayed OTC Markets 13:09:54 2026-08-21 EDT			5-day change	1st Jan Change
1.430 ^USD	-14.37%		-.--%	+175.00%

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI
06-01	Revium Rx. Announces CFO Changes, Effective May 27, 2026	CI
05-14	Revium Rx. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-20	Revium Rx. Appoints Amir Avraham as Permanent Chief Executive Officer, Effective as of February 1, 2026	CI
04-20	Revium Rx. Appoints Shlomi Schwartzblat as Director and Chairman of the Board, Effective April 14, 2026	CI
03-31	Revium Rx. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	Revium Rx. Auditor Raises 'Going Concern' Doubt	CI
01-16	Revium Rx. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Revium Recovery Inc. Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	CI
25-10-03	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-02-14	Revium Rx. has filed an IPO in the amount of $5 million.	CI
25-02-03	Revium Recovery Inc. completed the acquisition of LipoVac, Ltd.	CI

25-10-21	Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections	GL
25-02-04	Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd.	GL
22-12-21	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd	AQ
22-12-20	Revium Recovery, Inc. Announces Letter of Intent to Acquire LipoVac Ltd.	AQ
20-12-17	Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS	GL

Manager	Title	Age	Since
Amir Avraham CEO	Chief Executive Officer	-	2025-05-21
Igor Bluvstein DFI	Director of Finance/CFO	46	2026-05-26
Inna Martin CEO	Chief Executive Officer	51	-

Director	Title	Age	Since
Inna Martin BRD	Director/Board Member	51	-
Matti Munk BRD	Director/Board Member	-	-
Yoram Druker BRD	Director/Board Member	-	-

Employees

Sector